Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden · Delayed Price · Currency is SEK 482.60
+5.20 (1.09%)
Nov 4, 2026, 5:29 PM CET
STO:SOBI Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 167,947 | 114,702 | 110,225 | 91,705 | 64,673 | 55,342 | |
Market Cap Growth | 48.93% | 4.06% | 20.20% | 41.80% | 16.86% | 12.98% |
Enterprise Value | 183,103 | 127,258 | 127,513 | 112,093 | 74,568 | 66,847 |
Last Close Price | 477.40 | 332.80 | 317.40 | 267.00 | 206.03 | 176.80 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.67 | 239.96 | 28.37 | 38.07 | 24.52 | 20.66 |
Forward PE | 20.85 | 19.17 | 25.06 | 32.77 | 19.95 | 24.22 |
PS Ratio | 5.21 | 4.06 | 4.24 | 4.14 | 3.44 | 3.56 |
PB Ratio | 3.66 | 3.04 | 2.74 | 2.71 | 2.44 | 2.38 |
P/FCF Ratio | 21.16 | 13.46 | 15.27 | 25.50 | 14.36 | 10.21 |
P/OCF Ratio | 21.09 | 13.39 | 14.92 | 20.52 | 14.13 | 10.12 |
PEG Ratio | 1.54 | 1.03 | 0.89 | 2.80 | 1.77 | 23.22 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.68 | 4.51 | 4.90 | 5.07 | 3.97 | 4.31 |
EV/EBITDA Ratio | 14.03 | 11.20 | 13.74 | 14.87 | 11.31 | 11.93 |
EV/EBIT Ratio | 18.42 | 15.79 | 21.90 | 24.09 | 16.50 | 17.62 |
EV/FCF Ratio | 23.08 | 14.93 | 17.67 | 31.16 | 16.56 | 12.33 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.36 | 0.31 | 0.42 | 0.61 | 0.34 | 0.47 |
Debt / EBITDA Ratio | 1.25 | 1.00 | 1.78 | 2.67 | 1.36 | 1.91 |
Debt / FCF Ratio | 2.05 | 1.35 | 2.32 | 5.70 | 2.02 | 2.01 |
Net Debt / Equity Ratio | 0.33 | 0.28 | 0.39 | 0.58 | 0.29 | 0.43 |
Net Debt / EBITDA Ratio | 1.18 | 0.92 | 1.68 | 2.60 | 1.17 | 1.76 |
Net Debt / FCF Ratio | 1.93 | 1.23 | 2.16 | 5.44 | 1.72 | 1.82 |
Asset Turnover | 0.42 | 0.40 | 0.35 | 0.35 | 0.37 | 0.32 |
Inventory Turnover | 1.20 | 1.29 | 1.42 | 1.38 | 1.31 | 1.08 |
Quick Ratio | 0.65 | 0.56 | 0.68 | 0.42 | 0.51 | 0.59 |
Current Ratio | 0.99 | 0.90 | 1.05 | 0.64 | 0.76 | 1.00 |
Return on Equity (ROE) | 16.28% | 1.22% | 10.46% | 7.98% | 10.61% | 12.34% |
Return on Assets (ROA) | 8.09% | 7.05% | 4.87% | 4.60% | 5.58% | 4.89% |
Return on Invested Capital (ROIC) | 13.20% | 15.49% | 9.38% | 8.65% | 10.66% | 9.15% |
Return on Capital Employed (ROCE) | 15.10% | 15.70% | 9.30% | 8.50% | 12.00% | 9.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.90% | 0.42% | 3.52% | 2.63% | 4.08% | 4.84% |
FCF Yield | 4.73% | 7.43% | 6.55% | 3.92% | 6.96% | 9.80% |
Buyback Yield / Dilution | -2.21% | -0.59% | -6.01% | -9.22% | -0.56% | 0.28% |